|
Home
>
Newsletters
>
The QMN Weekly Bulletin
> Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables
The QMN Weekly Bulletin
Oct. 26, 2012
| Vol.
4 No.
43
Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables
Ben Venue’s Bedford, Ohio, plant — in the news this past year for quality problems — has restarted a handful of production lines to make some of its critical-need drugs available again. Injectable generics such as radiotherapy drug amifostine, muscle relaxant vecuronium, chemotherapy drug gemcitabine and vasodilator phentolamine are once more returning to market shelves.
Generic Line |
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.